Financial Statements — EVOX
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 0.84 | 1.01 |
| Total Current Assets | 0.96 | 1.15 |
| Total Non-current Assets* | 245.51 | 243.37 |
| Total Assets | 246.47 | 244.52 |
| Accounts Payable | 0.16 | 0.14 |
| Total Current Liabilities | 0.27 | 0.26 |
| Total Non-current Liabilities* | 9.60 | 9.60 |
| Total Liabilities | 9.87 | 9.86 |
| Retained Earnings | (8.89) | (8.67) |
| Total Stockholder Equity | (8.89) | (8.67) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Selling, General & Admin | 0.22 | 0.17 |
| Operating Income | (0.22) | (0.17) |
| Net Income | 1.94 | 1.95 |
| Basic EPS | (0.01) | -- |
| Diluted EPS | (0.01) | -- |
Cash Flow Statement
(in thousands USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (144.87) | (109.83) |
| Financing Cash Flow | (23.42) | -- |
